×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
PR Newswire
Net Income. GAAP net income was $0.2 million, or less than $0.01 per share (basic and diluted) in the fourth quarter of 2023, compared to GAAP...
2 months ago
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Yahoo Lifestyle Canada
Dynavax Technologies Corp. (DVAX) announced that the company has amended its existing research and license agreement with AstraZeneca plc...
20 hours ago
Dynavax CFO Kelly MacDonald Is Making An Impact In The Biotech Industry
Forbes
Dynavax CFO Kelly MacDonald Is Making An Impact In The Biotech Industry. Jack McCullough. Senior Contributor Opinions expressed by Forbes...
1 month ago
Dynavax Technologies Enters Oversold Territory (DVAX)
Nasdaq
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.
4 days ago
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
The Motley Fool
Thank you, operator, and thank you all for joining us today. We appreciate your interest in Dynavax. We're excited about our recent...
2 months ago
While shareholders of Dynavax Technologies (NASDAQ:DVAX) are in the black over 5 years, those who bought a week ago aren't so fortunate
Simply Wall Street
Dynavax Technologies Corporation ( NASDAQ:DVAX ) shareholders might be concerned after seeing the share price drop 18...
2 weeks ago
Dynavax's Evolving Business Model
Life Science Leader
Dynavax will continue to focus on growing Heplisav-B revenue and market share, and hopes to expand the label into adults on hemodialysis. The...
2 months ago
40 Under 40: Alex Oh - Puget Sound Business Journal
The Business Journals
Leading intellectual property for vaccine maker Dynavax Technologies falls right at the intersection of Alex Oh's love for biology,...
4 days ago
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
PR Newswire
Preliminary HEPLISAV-B vaccine net product revenue for the fourth quarter and full year 2023 were approximately $51 million and $213 million,...
3 months ago
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023
Yahoo Finance
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023 · Revenue Growth: HEPLISAV-B net product revenue...
2 months ago